Cargando…
Tamoxifen-Activated CreERT Impairs Retinal Angiogenesis Independently of Gene Deletion
Autores principales: | Brash, James T., Bolton, Rebecca L., Rashbrook, Victoria S., Denti, Laura, Kubota, Yoshiaki, Ruhrberg, Christiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447161/ https://www.ncbi.nlm.nih.gov/pubmed/32635822 http://dx.doi.org/10.1161/CIRCRESAHA.120.317025 |
Ejemplares similares
-
Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice
por: Rossi, Martina, et al.
Publicado: (2023) -
In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control
por: Felker, Anastasia, et al.
Publicado: (2016) -
Cre toxicity in mouse models of cardiovascular physiology and disease
por: Rashbrook, Victoria S., et al.
Publicado: (2022) -
Comparison of Kindlin-2 deficiency-stimulated osteoarthritis-like lesions induced by Prg4(CreERT2) versus Aggrecan(CreERT2) transgene in mice
por: Yao, Qing, et al.
Publicado: (2023) -
Genetic targeting of Purkinje fibres by Sema3a-CreERT2
por: Li, Yan, et al.
Publicado: (2018)